4133 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Abnova Taiwan Corp. engages in researching, developing, manufacturing and selling antibodies. It also supplies medicines and human genes albumen. Its products include antibodies for virus, microbial, neuroscience and others. It operates through the following geographical segments: Taiwan, America, England, China, Japan, Germany, and Other Country. The company was founded on January 4, 2002 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
4133 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company